PET radiotracers facilitate the visualization of amyloid plaque density, enabling clinicians to assess people with cognitive impairment for Alzheimer’s and evaluate their response to treatment.
Diagnostic errors were involved in about one out of three adverse patient safety events analyzed in a new report from ECRI and the Institute for Safe Medication Practices PSO. Among the diagnostic ...